White Paper

Inorganic Growth Strategies in Precision Medicine
Forging New Paths to Value Creation in the Future of Healthcare.

July 6, 2021

Inorganic Growth Strategies in Precision Medicine During the last decade, the pharmaceutical industry has rapidly evolved from a model focused...

BlueBook

Diagnostics & Tools June 2021

Insilico has received $255mm in a round of funding led by Warburg Pincus Veracyte has agreed to acquire HalioDx for...

BlueBook

Diagnostics & Tools May 2021

CellCarta has acquired Reveal Biosciences NeoGenomics Laboratories has agreed to acquire Inivata for $390mm Caris Life Sciences has received $830mm...

BlueBook

Diagnostics & Tools April 2021

The Caryle Group has agreed to acquire Unchained Labs for $435mm DiaSorin has agreed to acquire Luminex for $2bb Avantor...

BlueBook

Diagnostics & Tools March 2021

Roche has agreed to acquire GenMark Diagnostics for $1.9bb Agilent Technologies has agreed to acquire Resolution Bioscience for approximately $700mm...

BlueBook

Diagnostics & Tools February 2021

Veracyte has agreed to acquire Decipher Biosciences for $670mm Exact Sciences Corporation has agreed to acquire Ashion Analytics for $140mm...

Research

Innovations in Pharmaceutical Development™
Crosstree’s in-depth guide to the most innovative people, companies, and solutions in pharma services.

February 8, 2021

Introducing Innovations in Pharmaceutical Development™ In this first-of-its-kind book, Crosstree profiles over 50 of the most innovative companies and thought...

Article

PharmaVOICE: February 2021

February 1, 2021

Fueled by the strong financial performance of Pharma Services, Diagnostics and Tools, and Digital Health companies and accelerated by the...

BlueBook

Diagnostics & Tools January 2021

Boston Scientific has agreed to acquire Preventice Solutions for $950mm Thermo Fisher Scientific has agreed to acquire Mesa Biotech for...

BlueBook

Diagnostics & Tools December 2020

Philips has agreed to acquire BioTelemetry for $2.8bb Verily Life Sciences received a $700mm round of funding Everly Well received...